|
Article Tools | Search this Article | |||
|
Dextromethorphan
|
[top]History
Dextromethorphan was first patented as an antitussive under U.S. Patent 2,676,177[1] in 1954. It was the approved by the United States Food and Drug Administration in 1958 as a cough suppressant. It was immediately made available as an "Over the Counter" medicine under the brand name Romilar. In the mid 1970s, the recreational abilities of dextromethorphan were apparent within the turbulent American counter-culture and Romilar was removed from store shelves. Following Romilar's withdrawal from the market, companies such as the now-dominant Robitussin and Vicks began to manufacture dextromethorphan-containing cough syrups with an intentionally unpleasant taste when consumed in large quantities, in an attempt to limit abuse.[2] Although dextromethorphan was intentionally excluded from the Controlled Substances Act of 1970, public officials across the U.S. have threatened to reconsider its status should public abuse warrant it. The U.S. Office of Diversion Control indicates that the "DEA is currently reviewing DXM for possible control."[3] |
[top]Chemistry
Main article: Dextromethorphan ChemistryDextromethorphan is an optically-active dextrorotary enantiomer of levorphanol, both an opiate and analgesic which plays parent to various other NDMA receptor antagonists. Dextromethorphan's stereoisomer is levomethorphan, also an opioid analgesic, though it has never been clinically developed. As a stable, organic, bicylic comound, dextromethorphan is not soluble in water, however, it will readily dissolve in chloroform. It appears as a white crystalline powder (occasionally with a yellow tinting) when pure. It is most commonly found as monohydrated salt with hydrobromide. Newer, extended-release formulations contain dextromethorphan bonded to a polystyrene sulfonic acid, usually abbreviated as polistirex, which the body's metabolism slowly dissolves. |
[top]Side-effects
Use of label-prescribed dextromethorphan doses has the ability to produce any of the following symptoms:
Recreational doses (those significantly exceeding label-prescribed amounts), in addition to the aforementioned side-effects, can produce a number of additional conditions including:
|
[top]Methods of DXM Abuse
[top]Smoking DXMDextromethorphan reacts with oxygen at room temperature, though not at any appreciable rate. However, at 395-397 Kelvin, Dextromethorphan Hydrobromide's melting point, this changes and Dextromethorphan reacts with oxygen to produce some very toxic chemicals. Free ("freebase") Dextromethorphan will also react with oxygen at its melting point. Anyone attempting to smoke Dextromethorphan in the presence of oxygen under normal atmospheric conditions will only end up inhaling nasty compounds such as nitric oxide and the organic products of combustion. This information is easily verified by looking at a Material Safety Data Sheet for this substance. Dextromethorphan reacts rapidly with oxygen at temperatures above 360 Kelvin. It is in everyone's best interest to know that Dextromethorphan is not "smokeable". |
[top]Forms of DXM
[top]Dextromethorphan HydrobromideDextromethorphan Hydrobromide[/h] This is what you get when you react DXM with hydrobromic acid. This is what is most commonly used for cough suppressants and for recreational use. This produces different effects on different doses. We refer to them as plateaus, and there are 4 of them. [top]Dextromethorphan PolistirexDextromethorphan Polistirex is another form of DXM that is time-released. The DXM itself is surrounded by a think plastic coating, which is slowly degraded during digestion, releasing the DXM. This is used in some cough medicines in a suspension along with DXM HBr, so when some of the DXM has worn off, then some more will kick in. Some people prefer the extended length of the "trips" this form of DXM offers, and some use this form in conjunction with DXM HBr to maintain a lengthy state of intoxication with a very noticable peak. |
[top]References
|
|
Posting Rules |